PHARMO Institute, part of Lumanity

PHARMO Institute for Drug Outcomes Research is a healthcare startup based in The Netherlands founded in 1999. The company's slogan "Harnessing patient-centric data to elucidate the practical benefits of medications tailored to specific individuals" reflects its core mission of utilizing patient-focused data to provide a practical understanding of medication efficacy for specific patients.

PHARMO offers research insights into disease epidemiology, drug use, healthcare resource utilization, health outcomes, risk management, patient tracking for outcomes and validation, drug safety, and health economic support. Their primary areas of focus encompass respiratory disorders, mother-child health, cancer and autoimmune diseases, as well as metabolic and cardiovascular diseases.

With their focus on leveraging patient data for tailored drug outcomes research, PHARMO is positioned at the intersection of healthcare and data-driven insights. As of now, the company has not disclosed its last investment or the related investors. With its pioneering approach to patient-centric drug outcomes research, PHARMO Institute for Drug Outcomes Research is poised to make significant strides in the healthcare industry, driven by its commitment to personalized medicine and data-driven insights.